Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

492.216
+1.1110.23%
Number of Gainers:27
Number of Losers:23
Number of Flat:1
PE:- -
High:494.856
Open:491.038
Low:485.429
Close:491.104
Volume:505.55M
Turnover:14.63B
Market Cap:3.11T
Float Cap:2.18T

Loading ...

China Resources Beer Likely to Face Headwinds in 2H

Dow Jones
·
Aug 20

KEYMED BIO-B Surges Over 6% Pre-Market as H1 Drug Sales Climb 132%

Deep News
·
Aug 20

UBS Adjusts China Res Beer Price Target Downward, Keeps Buy Rating

Stock News
·
Aug 20

Simcere Pharma Surges Nearly 5% in Morning Trading as Huatai Retains Buy Rating

Deep News
·
Aug 20

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Stock News
·
Aug 20

Wang Xingxing Unveils Latest Team Initiatives: Advancing Autonomous Evolution of Physical AI Robot Models

Deep News
·
Aug 20

China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug

THOMSON REUTERS
·
Aug 20

EVEREST MED Surges Over 89% at Market Open on Strong First-Half Revenue of 1.148 Billion Yuan, Up 157% Year-on-Year

Deep News
·
Aug 20

Everest Medicines Surges 15% as Moderna's Cancer Vaccine Breakthrough Revitalizes mRNA Sector

Stock News
·
Aug 20

Hong Kong Stocks Open Higher: Hang Seng Index Up 1.11%, Tech Shares Rally, Gold and Biotech Stocks Surge

Deep News
·
Aug 20

Test Driving That Drone or Just Renting? Why the Chinese Government Needs to Know.

Dow Jones
·
Aug 20

Central China New Life Expects HY Net Loss of RMB 20 Million-RMB 35 Million

Reuters
·
Aug 19

CC NEW LIFE Issues Profit Warning, Expects H1 Net Loss of RMB 20-35 Million, Reversing from Year-Ago Profit

Stock News
·
Aug 19

Central China New Life - Expects Net Loss of RMB20 Mln-RMB35 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 19

Central China New Life - Expected Net Loss in Hy Mainly Due to Increased Impairment Losses on Receivables

THOMSON REUTERS
·
Aug 19

KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing

Stock News
·
Aug 19

Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market

Reuters
·
Aug 19

KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026

THOMSON REUTERS
·
Aug 19

KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing

THOMSON REUTERS
·
Aug 19

Keymed Biosciences Swings to FY26 H1 Profit of RMB 1.22 Billion; Revenue Rises 24% to RMB 617.07 Million

Reuters
·
Aug 19